Skip to main content

Table 2 Concomitant medications at the initiation of treatment

From: Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patients

 

Patients

Percentage of all cases (%)

PPI

 Rabeprazole

38

36

 Esomeprazole

23

22

 Vonoprazan

15

14

 Omeprazole

4

4

NSAIDs

 Loxoprofen

17

16

 Celecoxib

7

7

 Naproxen

5

5

 Meloxicam

1

1

 Tiaramide

1

1

Kampo medicines

 Goshajinkigan

23

22

 Daikentyuto

3

3

 Rikkunshito

2

2

 Hangeshashinto

2

2

 Ninjinyoeito

1

1

 Juzentaihoto

1

1

 Kakkonto

1

1

 Bukuryoingohangeshashinto

1

1

Others

Pregabalin

8

8

  1. PPI Proton pump inhibitor, NSAIDs Non-steroidal anti-inflammatory drugs